Layers of mutualism with commensal bacteria protect us from intestinal inflammation

Gut

Volumn 55, Issue 2, 2006, Pages 276-284

  Mueller, C ^b   Macpherson, A J ^a,c  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF BERN   (Switzerland)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

BACTERIUM; CD4+ T LYMPHOCYTE; COMMENSAL BACTERIUM; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; GENE LOCUS; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MUCOSAL IMMUNITY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMBIOSIS;

ANIMALS; BACTERIA; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; MICE; SYMBIOSIS;

EID: 30944458581     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.054098     Document Type: Review

References (134)

1. Du Pasquier L, Flajnik M. Origin and evolution of the immune system. In: Paul WE, eds. Fundamental immunology, 4th edn. Philadelphia: Lippincott-Raven, 1999:605-99.
2. Macpherson AJ, Harris N. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4:478-85.
3. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-18.
4. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine (cites personal communication from Joshua Lederberg). Science 2001;291:881-4.
5. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718-23.
6. Hooper LV, Stappenbeck TS, Hong CV, et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
7. Benveniste J, Lespinats G, Solomon J. Serum and secretory IgA in axenic and holoxenic mice. J Immunol 1971;107:1656-62.
8. Benveniste J, Lespinats G, Adam C, et al. Immunoglobulins in intact, immunized, and contaminated axenic mice: study of serum IgA. J Immunol 1971;107:1647-55.
9. Guy-Grand D, Griscelli C, Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med 1978;148:1661-77.
10. Helgeland L, Vaage JT, Rolstad B, et al. Regional phenotypic specialization of intraepithelial lymphocytes in the rat intestine does not depend on microbial colonization. Scand J Immunol 1997;46:349-57.
11. Helgeland L, Vaage JT, Rolstad B, et al. Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine. Immunology 1996;89:494-501.
12. Yamanaka T, Helgeland L, Farstad IN, et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 2003;170:816-22.
13. Bos NA, Kimura H, Meeuwsen CG, et al. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol 1989;19:2335-9.
14. Bos NA, Ploplis VA. Humoral immune response to 2,4-dinitrophenyl-keyhole limpet hemocyanin in antigen-free, germ-free and conventional BALB/c mice. Eur J Immunol 1994;24:59-65.
15. Wostmann BS, Pleasants JR, Bealmear P. Dietary stimulation of immune mechanisms. Fed Proc 1971;30:1779-84.
16. Wostmann BS, Pleasants JR. The germ-free animal fed chemically defined diet: a unique tool. Proc Soc Exp Biol Med 1991;198:539-46.
17. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-64.
18. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
19. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-4.
20. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
21. Fukushima K, Sasaki I, Ogawa H, et al. Colonization of microflora in mice: mucosal defense against luminal bacteria. J Gastroenterol 1999;34:54-60.
22. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-7.
23. Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal paneth cells in response to bacteria. Nature Immunol 2000;1:113-18.
24. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-4.
25. Bjarnason I, Macpherson AJ, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
26. Daig R, Andus T, Aschenbrenner E, et al. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996;38:216-22.
27. Mazzucchelli L, Hauser C, Zgraggen K, et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994;144:997-1007.
28. Z'Graggen K, Walz A, Mazzucchelli L, et al. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 1997;113:808-16.
29. Keates S, Keates AC, Mizoguchi E, et al. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol 1997;273:G75-82.
30. Shibahara T, Wilcox JN, Couse T, et al. Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes. Gastroenterology 2001;120:60-70.
31. Dwinell MB, Luegering N, Eckmann L, et al. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 2001;120:49-59.
32. Gewirtz AT, Navas TA, Lyons S, et al. Cutting edge: bacterial flagellin activates basolaterally expressed tlr5 to induce epithelial proinflammatory gene expression. J Immunol 2001;167:1882-5.
33. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
34. Crowe PT, Marsh MN. Morphometric analysis of intestinal mucosa. VI-Principles in enumerating intra-epithelial lymphocytes. Virchows Arch 1994;424:301-6.
35. Deusch K, Pfeffer K, Reich K, et al. Phenotypic and functional characterization of human TCR gamma delta+ intestinal intraepithelial lymphocytes. Curr Top Microbiol Immunol 1991;173:279-83.
36. Goodman T, Lefranccois L. Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature 1988;333:855-8.
37. Macpherson AJ, Martinic MM, Harris N. The functions of mucosal T cells in containing the indigenous flora of the intestine. Cell Mol Life Sci 2003;59:2088-96.
38. Pennington DJ, Silva-Santos B, Shires J, et al. The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells. Nat Immunol 2003;4:991-8.
39. Guy Grand D, Rocha B, Mintz P, et al. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med 1994;180:673-9.
40. Poussier P, Teh HS, Julius M. Thymus-independent positive and negative selection of T cells expressing a major histocompatibility complex class I restricted transgenic T cell receptor alpha/beta in the intestinal epithelium. J Exp Med 1993;178:1947-57.
41. Rocha B, von Boehmer H, Guy-Grand D. Selection of intraepithelial lymphocytes with CD8 alpha/alpha co-receptors by self-antigen in the murine gut. Proc Natl Acad Sci U S A 1992;89:5336-40.
42. Leishman AJ, Gapin L, Capone M, et al. Precursors of functional MHC class I- or class II-restricted CD8alphaalpha(+) T cells are positively selected in the thymus by agonist self-peptides. Immunity 2002;16:355-64.
43. Arstila T, Arstila TP, Calbo S, et al. Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med 2000;191:823-34.
44. Lundqvist C, Melgar S, Yeung MM, et al. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol 1996;157:1926-34.
45. Leon F, Roldan E, Sanchez L, et al. Human small-intestinal epithelium contains functional natural killer lymphocytes. Gastroenterology 2003;125:345-56.
46. Chott A, Gerdes D, Spooner A, et al. Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function. Am J Pathol 1997;151:435-42.
47. Muller S, Lory J, Corazza N, et al. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol 1998;152:261-8.
48. Reinhardt RL, Khoruts A, Merica R, et al. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001;410:101-5.
49. Kim SK, Reed DS, Heath WR, et al. Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol 1997;159:4295-306.
50. Muller S, Buhler-Jungo M, Mueller C. Intestinal intraepithelial lymphocytes exert potent protective cytotoxic activity during an acute virus infection. J Immunol 2000;164:1986-94.
51. Powrie F, Leach MW, Mauze S, et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-71.
52. Morrissey PJ, Charrier K, Braddy S, et al. CD4+ T cells that express high levels of CD45RB induce wasting disease transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993;178:237-44.
53. Saurer L, Seibold I, Rihs S, et al. Virus-induced activation of self-specific TCRαβ CD8αα intraepithelial lymphocytes does not abolish their self-tolerance in the intestine. J Immunol 2004;172:4176-83.
54. Poussier P, Ning T, Banerjee D, et al. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med 2002;195:1491-7.
55. Allez M, Brimnes J, Dotan I, et al. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002;123:1516-26.
56. Colder JP, Doe WF. Isolation and preliminary characterization of human intestinal macrophages. Gastroenterology 1983;84:795-802.
57. Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 2004;127:300-9.
58. Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003;124:1866-78.
59. Kanai T, Ilyama R, Ishikura T, et al. Role of the innate immune system in the development of chronic colitis. J Gastroenterol 2002;37(suppl 14):38-42.
60. Smith PD, Smythies LE, Mosteller-Barnum M, et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001;167:2651-6.
61. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000.
62. Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410:1103-7.
63. Schenk M, Bouchon A, Birrer S, et al. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 2005;174:517-24.
64. Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
65. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
66. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
67. Hampe J, Cuthbert A, Croucher PJP, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
68. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
69. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-72.
70. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-12.
71. Girardin SE, Travassos LH, Herve M, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003;278:41702-8.
72. Watanabe T, Kitani A, Murray P, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type-1 responses. Nat Immunol 2004;5:800-8.
73. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005;307:734-8.
74. Pauleau AL, Murray PJ. Role of Nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003;23:7531-9.
75. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
76. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
77. Breese E, Braegger CP, Corrigan CJ, et al. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-31.
78. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-7.
79. Huang F-P, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to t cell areas of mesenteric lymph nodes. J Exp Med 2000;191:435-44.
80. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996;183:237-47.
81. Iwasaki A, Kelsall BL. Unique functions of cd11b(+), cd8alpha(+), and double-negative peyer's patch dendritic cells. J Immunol 2001;166:4884-90.
82. Becker C, Wirtz S, Blessing M, et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 2003;112:693-706.
83. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004;113:1296-306.
84. Macpherson AJ, Gatto D, Sainsbury E, et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000;288:2222-6.
85. Beltinger J, McKaig BC, Makh S, et al. Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response. Am J Physiol 1999;277:C271-9.
86. Bhan AK, Mizoguchi E, Smith RN, et al. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999;169:195-207.
87. Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:246-59.
88. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521.
89. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52.
90. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
91. Grogan JL, Locksley RM. T helper cell differentiation: on again, off again. Curr Opin Immunol 2002;14:366-72.
92. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-82.
93. Qiao L, Schurmann G, Betzler M, et al. Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 1991;101:1529-36.
94. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
95. Huang CT, Workman CJ, Flies D, et al. Role of LAG-3 in regulatory T cells. Immunity 2004;21:503-13.
96. Khoo UY, Proctor IE, Macpherson AJ. CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 1997;158:3626-34.
97. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003;9:9.
98. Makita S, Kanai T, Oshima S, et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004;173:3119-30.
99. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
100. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
101. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003;170:3939-43.
102. Corazza N, Eichenberger S, Eugster H-P, et al. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2-/- mice upon transfer of CD4+CD45RBhi T cells. J Exp Med 1999;190:1479-92.
103. Johansson-Lindbom B, Svensson M, Wurbel MA, et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue: requirement for GALT dendritic cells and adjuvant. J Exp Med 2003;198:963-9.
104. Bamias G, Martin C, Mishina M, et al. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 2005;128:654-66.
105. Warnock RA, Campbell JJ, Dorf ME, et al. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000;191:77-88.
106. Iwata M, Hirakiyama A, Eshima Y, et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004;21:527-38.
107. Austrup F, Rebstock S, Kilshaw PJ, et al. Transforming growth factor-beta 1-induced expression of the mucosa- related integrin alpha E on lymphocytes is not associated with mucosa-specific homing. Eur J Immunol 1995;25:1487-91.
108. Kunkel EJ, Kim CH, Lazarus NH, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001-10.
109. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
110. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 1999;48:137-43.
111. Boirivant M, Fuss IJ, Chu A, et al. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998;188:1929-39.
112. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
113. Matsumoto S, Okabe Y, Setoyama H, et al. Inflammatory bowel disease-like enteritis and coecitis in a senescence accelerated mouse 1l/Yit strain. Gut 1998;43:71-8.
114. Kosiewicz MM, Nast CC, Krishnan A, et al. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 2001;107:695-702.
115. Iqbal N, Oliver JR, Wagner FH, et al. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 2002;195:71-84.
116. Sundberg JP, Elson CO, Bedigian H, et al. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 1994;107:1726-35.
117. Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
118. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998;161:5733-44.
119. Maggio-Price L, Shows D, Waggie K, et al. Helicobacter bills infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 2002;160:739-51.
120. Fiorucci S, Distrutti E, Mencarelli A, et al. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Digestion 2002;66:246-56.
121. Wirtz S, Finotto S, Kanzler S, et al. Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF-plus IFN- gamma-producing CD4+ T cells that respond to bacterial antigens. J Immunol 1999;162:1884-8.
122. Bush TG, Savidge TC, Freeman TC, et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998;93:189-201.
123. Kontoyiannis D, Pasparakis M, Pizarro TT, et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU- rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98.
124. Hahm KB, Im YH, Parks TW, et al. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001;49:190-8.
125. Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000;118:1094-105.
126. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
127. Schultz M, Tonkonogy SL, Sellon RK, et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 1999;276:G1461-72.
128. Erdman S, Fox JG, Dangler CA, et al. Typhlocolitis in NF-kappa B-deficient mice. J Immunol 2001;166:1443-7.
129. Veltkamp C, Tonkonogy SL, De Jong YP, et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. Gastroenterology 2001;120:900-13.
130. Watanabe M, Ueno Y, Yajima T, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998;187:389-402.
131. Matsuda JL, Gapin L, Sydora BC, et al. Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. J Immunol 2000;164:2797-806.
132. Rudolph U, Finegold MJ, Rich SS, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2- deficient mice. Nat Genet 1995;10:143-50.
133. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998;9:81-91.
134. Bamias G, Marini M, Moskaluk CA, et al. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 2002;169:5308-14.